How many insider trades does FilingIQ track for AARD?

FilingIQ tracks 32 Form 4 insider transactions for AARD (Aardvark Therapeutics, Inc.), covering filings from Feb 14, 2025 onwards. 4 of those were filed in the last 90 days.

Are AARD insiders net buyers or net sellers?

Across the full Form 4 history for AARD, 12 transactions (38%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does AARD insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is AARD in?

Aardvark Therapeutics, Inc. (AARD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $265.63M.

AARD insider trading

Healthcare

Aardvark Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

38% / 0%

Market cap

$265.63M

About Aardvark Therapeutics, Inc.

Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Its lead product candidate is ARD-101, an oral gut-restricted small-molecule agonist of certain targeting bitter taste receptors expressed in the gut lumen, which is in the Phase 3 clinical trial for hyperphagia associated with Prader-Willi Syndrome, as well as in the Phase 2 clinical trial for hyperphagia associated with acquired hypothalamic obesity resultant from the treatment of craniopharyngioma, including surgery or radiation. The company is also developing ARD-201, which is in the Phase 1 clinical trial for the treatment of obesity. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

Company website: aardvarktherapeutics.com

AARD insider activity at a glance

FilingIQ has scored 32 insider transactions for AARD since Feb 14, 2025. The most recent filing in our index is dated Aug 14, 2026.

Across the full history, 12 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on AARD insider trades is 54.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live AARD trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 983

UNITED THERAPEUTICS Corp

NUVL 195

Nuvalent, Inc.

KYMR 193

Kymera Therapeutics, Inc.

GH 192

Guardant Health, Inc.

Hims & Hers Health, Inc.

Frequently asked

How many insider trades does FilingIQ track for AARD?: FilingIQ tracks 32 Form 4 insider transactions for AARD (Aardvark Therapeutics, Inc.), covering filings from Feb 14, 2025 onwards. 4 of those were filed in the last 90 days.
Are AARD insiders net buyers or net sellers?: Across the full Form 4 history for AARD, 12 transactions (38%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does AARD insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is AARD in?: Aardvark Therapeutics, Inc. (AARD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $265.63M.

Methodology & sources

Every AARD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.